Oral aversion to dietary sugar, ethanol and glycerol correlates with alterations in specific hepatic metabolites in a mouse model of human citrin deficiency.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular Genetics and Metabolism

• Publication date

  2017-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ymgme.2017.02.004PMID 28259708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods of Enzymatic Analysis

  2019cited by this paper
• FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver.

  2016cited by this paper
• FGF21 Regulates Sweet and Alcohol Preference.

  2016cited by this paper
• Mechanism for increased hepatic glycerol synthesis in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse: Urine glycerol and glycerol 3-phosphate as potential diagnostic markers of human citrin deficiency.

  2015cited by this paper
• Mitochondrial transporters of the SLC25 family and associated diseases: a review

  2014cited by this paper
• Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress

  2014cited by this paper
• The mitochondrial transporter family SLC25: identification, properties and physiopathology.

  2013cited by this paper
• Fast determination of adenosine 5'-triphosphate (ATP) and its catabolites in royal jelly using ultraperformance liquid chromatography.

  2012cited by this paper
• Effects of supplementation on food intake, body weight and hepatic metabolites in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse model of human citrin deficiency.

  2012cited by this paper
• Metabolomic analysis reveals hepatic metabolite perturbations in citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mice, a model of human citrin deficiency.

  2011cited by this paper
• Dietary fat sensing via fatty acid oxidation in enterocytes: possible role in the control of eating.

  2011cited by this paper
• Genotypic and phenotypic features of citrin deficiency: five-year experience in a Chinese pediatric center.

  2011cited by this paper
• The characteristics of food intake in patients with type II citrullinemia.

  2011cited by this paper
• Conventional diet therapy for hyperammonemia is risky in the treatment of hepatic encephalopathy associated with citrin deficiency.

  2010cited by this paper
• Histological findings in the livers of patients with neonatal intrahepatic cholestasis caused by citrin deficiency

  2010cited by this paper
• Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase/malonyl-CoA signaling pathway.

  2009cited by this paper
• Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical and laboratory investigation of 13 subjects in mainland of China.

  2009cited by this paper
• Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report.

  2008cited by this paper
• Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.

  2008cited by this paper
• Reduced carbohydrate intake in citrin-deficient subjects

  2008cited by this paper
• Citrin/Mitochondrial Glycerol-3-phosphate Dehydrogenase Double Knock-out Mice Recapitulate Features of Human Citrin Deficiency*

  2007cited by this paper
• Citrin Deficiency: A Novel Cause of Failure to Thrive That Responds to a High-Protein, Low-Carbohydrate Diet

  2007cited by this paper
• Adult‐onset type II citrullinemia associated with idopathic hypertriglyceridemia as a preceding feature

  2006cited by this paper
• Homozygous SLC25A13 mutation in a Taiwanese patient with adult-onset citrullinemia complicated with steatosis and hepatocellular carcinoma.

  2006cited by this paper
• Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2).

  2005cited by this paper
• Inbred mouse strain survey of sucrose intake.

  2005cited by this paper
• Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier.

  2005cited by this paper
• Slc25a13-Knockout Mice Harbor Metabolic Deficits but Fail To Display Hallmarks of Adult-Onset Type II Citrullinemia

  2004cited by this paper
• Some processes of energy saving and expenditure occurring during ethanol perfusion in the isolated liver of fed rats; a Nuclear Magnetic Resonance study.

  2004cited by this paper
• Chronic pancreatitis associated with adult-onset type II citrullinemia: clinical and pathologic findings.

  2004cited by this paper
• Hepatocellular carcinoma in a case of adult-onset type II citrullinemia.

  2003cited by this paper
• Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease.

  2003cited by this paper
• Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD)

  2002cited by this paper
• Possible clinical and histologic manifestations of adult-onset type II citrullinemia in early infancy.

  2001cited by this paper
• Neonatal presentation of adult-onset type II citrullinemia

  2001cited by this paper
• Infantile cholestatic jaundice associated with adult-onset type II citrullinemia.

  2001cited by this paper
• Citrin and aralar1 are Ca2+‐stimulated aspartate/glutamate transporters in mitochondria

  2001cited by this paper
• Metabolic inhibitors synergistically decrease hepatic energy status and increase food intake.

  2000cited by this paper
• Fatty acid oxidation affects food intake by altering hepatic energy status.

  1999cited by this paper
• Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion.

  1999cited by this paper
• The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein

  1999cited by this paper
• Chloroformates in gas chromatography as general purpose derivatizing agents.

  1998cited by this paper
• Role of the liver in the metabolic control of eating: what we know--and what we do not know.

  1996cited by this paper
• Changes of Liver Metabolite Concentrations in Adults with Disorders of Fructose Metabolism after Intravenous Fructose by 31P Magnetic Resonance Spectroscopy

  1994cited by this paper
• Catabolism of adenine nucleotides and its relation with intracellular phosphorylated metabolite concentration during ethanol oxidation in perfused rat liver.

  1993cited by this paper
• Development of enzymes of glycerol metabolism in human fetal liver.

  1987cited by this paper
• The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase.

  1977cited by this paper
• Regulatory role of reducing-equivalent transfer from substrate to oxygen in the hepatic metabolism of glycerol and sorbitol.

  1973cited by this paper
• Control of the removal of reducing equivalents from the cytosol in perfused rat liver.

  1971cited by this paper
• Generation of extramitochondrial reducing power in gluconeogenesis.

  1967cited by this paper

• Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications

  2025cites this paper
• Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency

  2025cites this paper
• Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency: A Case Report and Literature Review

  2025cites this paper
• Current Understanding of Pathogenic Mechanisms and Disease Models of Citrin Deficiency

  2025cites this paper
• Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in Citrin Deficiency

  2024influential citation
• Pathogenic variants of the mitochondrial aspartate/glutamate carrier causing citrin deficiency

  2022cites this paper
• Analysis of daily energy, protein, fat, and carbohydrate intake in citrin-deficient patients: Towards prevention of adult-onset type II citrullinemia.

  2021cites this paper
• Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency: In vivo and in vitro studies of the aberrant transcription arising from two novel splice-site variants in SLC25A13.

  2021cites this paper
• Molecular epidemiologic study of citrin deficiency by screening for four reported pathogenic SLC25A13 variants in the Shaanxi and Guangdong provinces, China

  2021cites this paper
• Citrin deficiency mimicking mitochondrial depletion syndrome

  2020cites this paper
• AGC2 (Citrin) Deficiency—From Recognition of the Disease till Construction of Therapeutic Procedures

  2020influential citation
• Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2.

  2019cites this paper
• mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency.

  2019cites this paper
• Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model

  2019cites this paper
• Molecular and clinical characterization of citrin deficiency in a cohort of Chinese patients in Hong Kong

  2018cites this paper